Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.

ABSTRACT: Glutamine dependence is a unique metabolic defect seen in cutaneous melanoma (CM), directly influencing the treatment and prognosis. Here, we investigated the associations between 6025 common single-nucleotide polymorphisms (SNPs) in 77 glutamine metabolic pathway genes with CM-specific survival (CMSS) using genotyping datasets from two published genome-wide association studies (GWASs). In the single-locus analysis, 76 SNPs were found to be significantly associated with CMSS (P??C, LGSN rs12663017T?>?A, and NOXRED1 rs8012548A?>?G) independently predicted CMSS, with an effect-allele attributed adjusted hazards ratio of 1.52 (95% confidence interval?=?1.19-1.93) and P?

SUBMITTER: Chen K 

PROVIDER: S-EPMC7504905 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature